Total Funding
79
54
Total FundingPre-Seed raised
Growth Score 79 in past quarter
-6 pts
Heat Score 54 in past quarter
-38 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
140058
STIMIT is a medtech company that reinvents intensive care by empowering patients to breathe
- Ronja Mueller Bruhn: Co-Founder - CEO - Board Member
- Thomas Degen: CSOPast Role: Biovotion, VD Development
Hamilton Medical
About the Company
STIMIT is a medtech company that is going to re-invent intensive care by empowering patients to breathe.
50% of all mechanically ventilated patients experience loss of intact breathing function, caused by a weak diaphragm. 40% of time in intensive care is spent only to wean patients from the ventilator, thereby rebuild diaphragm function and
rebuild ability to breathe. STIMIT's first therapy enabled by our device is being developed to keep the diaphragm active, strong and functional.
A strong diaphragm is essential to liberate patients from ventilators, shorten ventilation time and reduce morbidity and mortality.
Our second generation therapy is then going to open new doors to reinvent the way patients inhale air.